FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer

NCT03944434 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Ribociclib
DRUG: Aromatase Inhibitors, non steroideal
DRUG: LHRH agonist

Sponsor

Fondazione Sandro Pitigliani

Collaborators

[object Object]